Sun Pharma Advanced Research Company Limited Cash Flow-to-Debt Ratio
Sun Pharma Advanced Research Company Limited cash flow-to-debt ratio. Sun Pharma Advanced Research Company Limited (SPARC) has a Cash Flow-to-Debt Ratio of -0.17x as of September 2025, meaning its operating cash flow of Rs-1.16 Billion could theoretically repay 0% of its total liabilities (Rs6.67 Billion) in one year. Check SPARC cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Sun Pharma Advanced Research Company Limited (2007–2025)
Cash flow-to-debt ratio of Sun Pharma Advanced Research Company Limited from 2007 to 2025. Historical debt coverage capacity for Sun Pharma Advanced Research Company Limited across 19 annual periods. Check Sun Pharma Advanced Research Company Lim (SPARC) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Sun Pharma Advanced Research Company Limited Cash Flow-to-Debt Ratio by Year (2007–2025)
Sun Pharma Advanced Research Company Limited cash flow-to-debt ratio by year from 2007 to 2025. Year-by-year debt coverage analysis for Sun Pharma Advanced Research Company Limited. For the full cash flow conversion analysis, see SPARC cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.65x | Rs-3.60 Billion | Rs5.52 Billion | ▲ +40.8% |
| 2024 | -1.10x | Rs-4.29 Billion | Rs3.89 Billion | ▼ -406.2% |
| 2023 | -0.22x | Rs-691.20 Million | Rs3.17 Billion | ▲ +74.0% |
| 2022 | -0.84x | Rs-2.08 Billion | Rs2.49 Billion | ▼ -119.2% |
| 2021 | -0.38x | Rs-1.52 Billion | Rs3.98 Billion | ▲ +47.3% |
| 2020 | -0.72x | Rs-2.11 Billion | Rs2.91 Billion | ▲ +56.9% |
| 2019 | -1.68x | Rs-1.72 Billion | Rs1.02 Billion | ▼ -14.2% |
| 2018 | -1.47x | Rs-1.83 Billion | Rs1.24 Billion | ▼ -31.6% |
| 2017 | -1.12x | Rs-1.28 Billion | Rs1.14 Billion | ▼ -236.1% |
| 2016 | -0.33x | Rs-442.12 Million | Rs1.33 Billion | ▲ +63.9% |
| 2015 | -0.92x | Rs-395.76 Million | Rs428.71 Million | ▼ -210.7% |
| 2014 | 0.83x | Rs368.95 Million | Rs442.40 Million | ▲ +188.0% |
| 2013 | -0.95x | Rs-953.44 Million | Rs1.01 Billion | ▼ -107.8% |
| 2012 | -0.46x | Rs-694.49 Million | Rs1.52 Billion | ▼ -1409.0% |
| 2011 | 0.03x | Rs25.05 Million | Rs718.75 Million | ▼ -84.0% |
| 2010 | 0.22x | Rs126.34 Million | Rs581.15 Million | ▼ -77.9% |
| 2009 | 0.98x | Rs254.54 Million | Rs258.75 Million | ▲ +180.5% |
| 2008 | -1.22x | Rs-203.92 Million | Rs166.91 Million | ▼ -16378.4% |
| 2007 | -0.01x | Rs-412.00K | Rs55.57 Million | — |